GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enzon Pharmaceuticals Inc (STU:EZ1) » Definitions » Net Interest Income (for Banks)

Enzon Pharmaceuticals (STU:EZ1) Net Interest Income (for Banks)


View and export this data going back to . Start your Free Trial

What is Enzon Pharmaceuticals Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Enzon Pharmaceuticals (STU:EZ1) Business Description

Traded in Other Exchanges
Address
20 Commerce Drive, Suite 135, Cranford, NJ, USA, 07016
Enzon Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the provision of licensing arrangements related to sales of drug products that utilize its proprietary technology. The company earns revenue in the form of royalties. Primary source of royalty revenues derived from the sales of PegIntron, which is marketed by Merck.